Olfactory dysfunction is considered a pre-cognitive biomarker of Alzheimer's disease (AD).
Because the olfactory system is highly conserved across species, mouse models …

Alzheimer's disease (AD) is the most common form of dementia. Although previous studies
have selectively investigated the localization of amyloid-beta (Aβ) deposition in certain brain …

Alzheimer's disease is the most common cause of dementia, and it is one of the leading
causes of death globally. Identification and validation of biomarkers that herald the onset …

Introduction: The aim of this study was to assess the relationship between olfactory cleft
width/volume and COVID-19-related anosmia. Methods: This study consisted of PCR-proven …

The temporal course and the severity of the involution of sensory systems through aging can
be critical since they ensure the ability to perceive and recognize the world. In older people …

Alzheimer's disease (AD) is a progressive neurodegenerative disorder and the most
common form of dementia. Approximately 50% of AD patients show anxiety and depressive …

Although olfactory deficits have been found in patients with early-stage Alzheimer's disease
(AD), the underlying mechanisms remain unclear. Here we investigated whether and how …

The prevalence of Alzheimer's disorder (AD) is increasing worldwide, and the co-morbid
anxiety is an important, albeit often neglected problem, which might appear early during …

Alzheimer's disease (AD) is the most common type of dementia and neurodegeneration. The
actual cause of AD progression is still unknown and no curative treatment is available …

Although Alzheimer's disease is most often studied in terms of memory impairments,
olfactory dysfunction begins in the early stages. We tested olfactory learning, sensitivity, and …